Intra Aortic Balloon Pumps Market Size , Share , Industry Trends , and Forecasts(2023 - 2030)
Intra-Aortic Balloon
Pump (IABP) Market Analysis Overview :
An Intra-Aortic
Balloon Pump (IABP) is a temporary circulatory assist device that supports
the heart's pumping function. It is used to treat patients with severe heart
failure or cardiogenic shock. The device works by inflating and deflating a
balloon within the aorta, thereby increasing blood flow to the heart and
reducing its workload.
The intra-aortic balloon pump is a category of therapeutic
device that enables the patient's heart to pump an adequate amount of blood.
The primary benefit of an intra-aortic balloon pump (IABP) is it enables blood
to flow more efficiently into the coronary arteries.
Key Market :
·
The IABP market is primarily driven by the
increasing prevalence of cardiovascular diseases such as heart failure and
myocardial infarction. The device is particularly useful in situations where
patients are awaiting heart transplantation or other advanced cardiac
therapies.
·
The major benefit associated with the employment
of an intra aortic balloon pump (IABP) includes it enhances the blood flow to
and from the heart.
·
the intra aortic balloon pump (IABP) is an ideal
solution for the treatment of coronary artery disease (CAD). The increasing
prevalence of coronary artery disease (CAD) is accelerating the utilization of
intra aortic balloon pumps (IABP).
·
the Centers for Disease Control and Prevention
(CDC), in 2021, approximately 1 out of 20 adults in the age group of 20 or more
are suffering from coronary artery disease (CAD) in the United States. Also,
the expenses associated with heart disease in the United States were approximately
USD 239.9 billion per annum
Restraints :
Several factors can restrain the growth of the IABP market:
·
High Cost: IABPs and their associated procedures
can be costly, limiting their accessibility in certain regions.
·
Complex Procedure: The implantation of an IABP
requires specialized expertise and advanced medical facilities.
·
Potential Complications: Like any medical
device, IABPs can have potential complications, such as bleeding, infection,
and aortic dissection.
·
The prominent factors such as the concerns
associated with fluid leak, distorted packaging, government interventions,
non-sterility, and others are leading to the recall of the intra-aortic balloon
pump product range.
·
The prime reason for the recall of the intra
aortic balloon pump was because of the leakage in the balloon. The leakage in
ballon can impact the blood entering into intra aortic balloon pump.
·
The recall of intra aortic balloon pump products
will impact the revenue growth of various companies, thereby posing a major
bottleneck for market growth in the upcoming year.
Opportunities :
Despite the challenges, the IABP market presents several
significant opportunities:
·
Growing Geriatric Population: The aging
population is more susceptible to cardiovascular diseases, increasing the
demand for IABPs.
·
Technological Advancements: Advances in IABP
technology, such as smaller, more efficient devices, can expand their
application and reduce complications.
·
Emerging Markets: The growing healthcare
infrastructure in emerging economies offers new opportunities for IABP
adoption.
·
The major players dealing in the intra aortic
balloon pump market are increasingly leveraging their technological potential
for the development of a new range of intra aortic balloon pumps to increase
their product offerings in the market.
·
intra aortic balloon pump manufacturers, having
their presence at the global level, are continuously investing in the
development of new methods with updated technological advancements to ensure
the development of new intra aortic balloon pumps to improve blood flow.
Key Players :
Several key players dominate the global IABP market:
·
Medtronic
·
LeMaitre Vascular
·
LivaNova
·
Getinge
Segmentation :
The IABP market can be segmented based on various factors:
·
Product Type: Disposable and reusable IABPs
·
End-User: Hospitals, Cardiac Centers
·
Region: North America, Europe, Asia-Pacific, and
Rest of the World
Regional Analysis :
The IABP market is global, with significant presence in
various regions:
·
North America: A major market, driven by
advanced healthcare infrastructure and a high prevalence of cardiovascular
diseases.
·
Europe: A significant market, with a focus on
innovative medical technologies.
·
Asia-Pacific: A rapidly growing market, driven
by increasing healthcare expenditure and rising incidence of cardiovascular
diseases.
·
The indication segment is categorized into
coronary artery diseases and chronic heart failure. In 2022, the coronary
artery diseases segment accounted for the highest market share in the intra
aortic balloon pumps market.
·
The key features related to intra aortic balloon
pump (IABP) include superior clinical support, designed and engineered for
economy & simplicity, easy-to-connect horizontal ports, and others. These
prominent features enable the intra aortic balloon pump to keep pace with the
blood flow to the heart.
·
This leads to efficient blood flow in the heart.
As a result, intra aortic balloon pumps (IABP) are utilized across hospitals
for high risk percutaneous coronary intervention (PCI). For instance, as of
June 2023, various hospitals at the global level, including the American
Hospital of Paris, France, Johns Hopkins Hospital, United States, and others
are some of the prominent hospitals that are providing intra aortic balloon
pump (IABP) treatments
Recent Developments :
The IABP market is constantly evolving, with several recent
developments:
·
Product Innovations: Key players are focusing on
developing advanced IABP systems with improved features and reduced
complications.
·
Clinical Trials: Ongoing clinical trials are
evaluating the effectiveness of IABPs in various clinical scenarios.
·
Regulatory Approvals: Regulatory approvals for
new IABP devices and indications are driving market growth.
·
In December 2022, Johnson & Johnson,
headquartered in the United States acquired Abiomed, based in Danvers, U.S.
Abiomed is a United States-based manufacturer of intra aortic balloon pumps.
The primary focus of Johnson & Johnson with this acquisition was to increase
the market position in the global intra aortic balloon pumps market.
·
In December 2022, Johnson & Johnson,
headquartered in the United States acquired Abiomed, based in Danvers, U.S.
Abiomed is a United States-based manufacturer of intra aortic balloon pumps.
The primary focus of Johnson & Johnson with this acquisition was to
increase the market position in the global intra aortic balloon pumps market.
Contact us:
Consegic
Business intelligence Pvt Ltd.
Contact no: (US) (505) 715-4344
Email: sales@consegicbusinessintelligence.com
Retail
Point of Sale Terminal Market
Agriculture
Biotechnology Market
Comments
Post a Comment